Moreover, post-transplant recurrence of FSGS has been found linked to decreased expression of the acid sphingomyelinase-like phosphodiesterase 3b (SMPDL3b) in podocytes, leading to increased sphingomyelin and decreased ceramide [18]. Here, SMPDL3B is linked to focal segmental glomerulosclerosis.